BI Asset Management Fondsmaeglerselskab A/S
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1778131
KOBENHAVN, G7
Position in BCRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$34,530
New position
Shares Held
3,453
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#265
of 316 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $42,638,294 across 9 Drug Manufacturers - Specialty & Generic names. BCRX ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
306,576 | $22,030,551 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
12,597 | $6,825,432 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
33,211 | $5,597,381 | |
| 4 | VTRS |
Viatris Inc
|
150,504 | $2,390,003 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
90,865 | $2,236,187 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
54,001 | $1,829,553 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
39,832 | $1,634,306 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
544 | $60,351 |
All Filings in BCRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,530 | 3,453 | Shares | Defined | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||